Partner with Alphanosos to discover and develop next-generation therapeutics and bioactive innovations powered by AI and natural biodiversity

Alphanosos is an AI-driven biotech company pioneering a new approach to therapeutic discovery by combining artificial intelligence, experimental biology, and the therapeutic potential of natural biodiversity.

We are seeking strategic partnerships with pharmaceutical companies, biotechnology firms, consumer health leaders, cosmetic companies, research organizations, and innovation-focused investors interested in accessing novel therapeutic and bioactive assets.

Our proprietary platform discovers patentable bioactive compositions capable of addressing complex biological systems and unmet medical needs, including infectious diseases, chronic inflammatory disorders, oncology, neurological diseases, metabolic disorders, and rare genetic conditions. The platform has already generated patented assets with preclinical and clinical validation, commercialized products, and ongoing collaborative programs with academic and industrial partners.

We are particularly interested in licensing agreements, co-development partnerships, clinical validation collaborations, joint research projects, and strategic investment opportunities. Together, we aim to accelerate the development of safer, more effective, and more sustainable healthcare solutions while reducing the cost, risk, and timelines traditionally associated with innovation.